Endocrine and Metabolic Disorders

Endocrine and metabolic diseases span a vast range of conditions. Together, they affect many millions of Americans and can profoundly decrease quality of life. NIDDK supports research on many of these conditions, including osteoporosis, cystic fibrosis, hypothyroidism, and obesity. Osteoporosis is a disease marked by reduced bone strength and linked to aging and fracture risk. 53 million people in the United States either have or are at risk for osteoporosis. Hypothyroidism, or underactive thyroid, affects about 4.6 percent of the U.S. population age 12 and older. More than 30,000 Americans have cystic fibrosis, an inherited disease in which salt and water cannot flow appropriately in many critical tissues. Despite dramatic advances in treatment and life expectancy, cystic fibrosis substantially reduces lifespan and its management is challenging.

      Related Conference of Endocrine and Metabolic Disorders

      July 20-21, 2026

      6th World Congress on Endocrine and Diabetes

      Paris, France
      September 29-30, 2026

      22nd World Congress on Endocrinology & Diabetes

      Paris, France
      October 20-21, 2026

      32nd World Diabetes & Heart Congress

      Amsterdam, Netherlands
      October 22-23, 2026

      4th World congress and Expo on Diabetes

      Toronto, Canada
      February 25-26, 2027

      20th International Summit on Diabetes

      London, UK
      March 23-24, 2027

      7th Annual Summit on Diabetes and Endocrinology

      Paris, France
      March 29-30, 2027

      8th Global summit on Diabetes and Endocrinology

      Amsterdam, Netherlands

      Endocrine and Metabolic Disorders Conference Speakers

        Recommended Sessions

        Related Journals

        Are you interested in